J
Janet K. Carreras
Publications - 4
Citations - 309
Janet K. Carreras is an academic researcher. The author has contributed to research in topics: Anal sac adenocarcinoma & Toceranib. The author has an hindex of 3, co-authored 4 publications receiving 264 citations.
Papers
More filters
Journal ArticleDOI
Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours
Cheryl A. London,Tamra Mathie,Nicole Stingle,Craig A. Clifford,Siobhan Haney,Mary K. Klein,Linda Beaver,Kate Vickery,David M. Vail,Betsey Hershey,Susan Ettinger,Andrew Vaughan,Francisco J. Alvarez,Lorin Hillman,Mike Kiselow,Doug H. Thamm,Mary Lynn Higginbotham,Meredith Gauthier,Erika L. Krick,Brenda Phillips,Tracy Ladue,Pam Jones,Jeffery Bryan,Virginia L. Gill,Andrew Novasad,Lisa Fulton,Janet K. Carreras,C. J. McNeill,Carolyn J. Henry,Sarah Gillings +29 more
TL;DR: Preliminary evidence that toceranib exhibits CB in dogs with certain solid tumours is provided, although future prospective studies are necessary to define its true activity.
Journal ArticleDOI
Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors
Kevin A. Hahn,Alfred M. Legendre,Neil G. Shaw,Brenda Phillips,Gregory K. Ogilvie,Deborah M. Prescott,Stephen W. Atwater,Janet K. Carreras,Susan E. Lana,Tracy Ladue,Anthony Rusk,Jean-Pierre Kinet,Patrice Dubreuil,Alain Moussy,Olivier Hermine +14 more
TL;DR: Control of disease at 6 months, but not best response at 6 weeks, was predictive of long-term survival in dogs treated with masitinib, which suggested that short-term response may be irrelevant for assessing clinical efficacy of tyrosine kinase inhibitors for treatment of MCTs.
Journal ArticleDOI
Efficacy of radiation therapy for incompletely resected grade-III mast cell tumors in dogs: 31 cases (1987-1998).
TL;DR: Without further treatment, incompletely excised grade-III mast cell tumors have high local-regional recurrence; local- Regional treatment with radiation may effectively be used to manage many such tumors.
Journal Article
Biological activity of toceranib (Palladia) in canine anal gland anal SAC adenocarcinoma (AGASACA)
Craig A. Clifford,David M. Vail,Doug H. Thamm,Jeffrey N. Bryan,Janet K. Carreras,L. Fulton,C. J. McNeill,C. Novosad,S. Ettinger,K. Freeman,L. Fineman,C. Cadile,K. Meleo,Pamela D Jones,Mary K. Klein,R. Gamblin,Cheryl A. London +16 more